The non-invasive cholesterol reader market size has grown rapidly in recent years. It will grow from $1.3 billion in 2025 to $1.5 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to rising cardiovascular disease prevalence, growing awareness of cholesterol monitoring, demand for non-invasive diagnostics, adoption in homecare settings, technological improvements in optical sensors.
The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to AI-enabled diagnostics, integration with telemedicine, miniaturization of devices, expansion in emerging markets, continuous real-time monitoring. Major trends in the forecast period include optical sensor-based devices, wearable cholesterol monitoring, portable diagnostic devices, integration with mobile health apps, home-based cholesterol testing.
The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the non-invasive cholesterol reader market in the coming years. Cardiovascular diseases, including coronary artery disease, stroke, and heart failure, are becoming increasingly common due to aging populations and sedentary lifestyles that elevate the risk of heart and vascular complications. Non-invasive cholesterol readers play a crucial role in early detection by enabling quick cholesterol measurements without the need for blood samples, supporting timely interventions to reduce the risk of heart attacks and strokes. For example, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, cardiovascular diseases caused 919,032 deaths in 2023, accounting for nearly one-third of all deaths. Hence, the growing incidence of cardiovascular diseases is contributing significantly to the expansion of the non-invasive cholesterol reader market.
The rise in healthcare expenditure is expected to boost the growth of the non-invasive cholesterol reader market. Healthcare expenditure encompasses total spending on medical services, treatments, and health-related goods aimed at improving population health. The steady increase in healthcare spending is primarily driven by the growing burden of chronic diseases, which demand ongoing care and management. Higher investment in healthcare facilitates the development and adoption of non-invasive diagnostic technologies that enable early cholesterol monitoring and reduce dependence on invasive procedures and costly hospital visits. For instance, according to the Office for National Statistics (ONS), a U.K.-based government agency, public healthcare spending in the United Kingdom reached $346 billion (£258 billion) in 2024, marking a 2.5% increase in real terms compared to 2023. Therefore, the rising healthcare expenditure is playing a pivotal role in driving demand for non-invasive cholesterol readers.
In August 2024, the National University of Singapore (NUS) collaborated with the Agency for Science, Technology and Research (ASTAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels through the skin. The partnership aims to design and commercialize a wearable hydrogel-based sensor for continuous, real-time, and non-invasive monitoring of biomarkers such as cholesterol and glucose on dry skin. This innovation is expected to enhance early disease detection, chronic disease management, and remote health monitoring. ASTAR, a Singapore-based public research agency focused on economic-driven innovation, is actively contributing to the advancement of non-invasive cholesterol reader technologies.
Major companies operating in the non-invasive cholesterol reader market are SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., PreVu Inc., CardioDiagnostics Inc., Scanadu Inc., Aidar Health Inc., Biovotion AG, Valencell Inc., Rockley Photonics Inc., LifeQ B.V., ChroniSense Medical Ltd., EchoLabs AI Inc., Grove Instruments LLC, MediBioSense Health Care, VitalConnect Inc., Sensible Medical Innovations Ltd., Current Health Ltd., Empatica Inc., BioIntelliSense Inc.
North America was the largest region in the non-invasive cholesterol reader market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-invasive cholesterol reader market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive cholesterol reader market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the non-invasive cholesterol reader market by increasing the cost of imported optical sensors, electronics, and handheld device components, particularly affecting wearable and portable readers manufactured in China and Southeast Asia. These tariffs have raised retail prices in North America and Europe, slowing adoption, but have also encouraged local manufacturing, supply chain diversification, and innovation in cost-efficient devices.
The non-invasive cholesterol reader market research report is one of a series of new reports that provides non-invasive cholesterol reader market statistics, including non-invasive cholesterol reader industry global market size, regional shares, competitors with a non-invasive cholesterol reader market share, detailed non-invasive cholesterol reader market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. This non-invasive cholesterol reader market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A non-invasive cholesterol reader is a medical device or diagnostic tool used to measure cholesterol levels in the body without the need for blood samples or needles. These devices commonly utilize technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external methods.
The primary product types of non-invasive cholesterol readers include wearable devices, handheld devices, and tabletop devices. Wearable devices are small, body-mounted instruments such as patches, bands, or wristbands that collect physiological data continuously or at regular intervals with minimal discomfort. These devices operate using technologies such as optical, ultrasound, electrical, and others. They are distributed through both online and offline channels and are used across various applications, including home care, hospitals and clinics, diagnostic centers, and other healthcare settings.
The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The non-invasive cholesterol reader market size is expected to see rapid growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to AI-enabled diagnostics, integration with telemedicine, miniaturization of devices, expansion in emerging markets, continuous real-time monitoring. Major trends in the forecast period include optical sensor-based devices, wearable cholesterol monitoring, portable diagnostic devices, integration with mobile health apps, home-based cholesterol testing.
The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the non-invasive cholesterol reader market in the coming years. Cardiovascular diseases, including coronary artery disease, stroke, and heart failure, are becoming increasingly common due to aging populations and sedentary lifestyles that elevate the risk of heart and vascular complications. Non-invasive cholesterol readers play a crucial role in early detection by enabling quick cholesterol measurements without the need for blood samples, supporting timely interventions to reduce the risk of heart attacks and strokes. For example, according to the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, cardiovascular diseases caused 919,032 deaths in 2023, accounting for nearly one-third of all deaths. Hence, the growing incidence of cardiovascular diseases is contributing significantly to the expansion of the non-invasive cholesterol reader market.
The rise in healthcare expenditure is expected to boost the growth of the non-invasive cholesterol reader market. Healthcare expenditure encompasses total spending on medical services, treatments, and health-related goods aimed at improving population health. The steady increase in healthcare spending is primarily driven by the growing burden of chronic diseases, which demand ongoing care and management. Higher investment in healthcare facilitates the development and adoption of non-invasive diagnostic technologies that enable early cholesterol monitoring and reduce dependence on invasive procedures and costly hospital visits. For instance, according to the Office for National Statistics (ONS), a U.K.-based government agency, public healthcare spending in the United Kingdom reached $346 billion (£258 billion) in 2024, marking a 2.5% increase in real terms compared to 2023. Therefore, the rising healthcare expenditure is playing a pivotal role in driving demand for non-invasive cholesterol readers.
In August 2024, the National University of Singapore (NUS) collaborated with the Agency for Science, Technology and Research (ASTAR) to develop a non-invasive sensor capable of detecting cholesterol and glucose levels through the skin. The partnership aims to design and commercialize a wearable hydrogel-based sensor for continuous, real-time, and non-invasive monitoring of biomarkers such as cholesterol and glucose on dry skin. This innovation is expected to enhance early disease detection, chronic disease management, and remote health monitoring. ASTAR, a Singapore-based public research agency focused on economic-driven innovation, is actively contributing to the advancement of non-invasive cholesterol reader technologies.
Major companies operating in the non-invasive cholesterol reader market are SiPhox Health Inc., Binah.ai Ltd., Occuity Ltd., PreVu Inc., CardioDiagnostics Inc., Scanadu Inc., Aidar Health Inc., Biovotion AG, Valencell Inc., Rockley Photonics Inc., LifeQ B.V., ChroniSense Medical Ltd., EchoLabs AI Inc., Grove Instruments LLC, MediBioSense Health Care, VitalConnect Inc., Sensible Medical Innovations Ltd., Current Health Ltd., Empatica Inc., BioIntelliSense Inc.
North America was the largest region in the non-invasive cholesterol reader market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-invasive cholesterol reader market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive cholesterol reader market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the non-invasive cholesterol reader market by increasing the cost of imported optical sensors, electronics, and handheld device components, particularly affecting wearable and portable readers manufactured in China and Southeast Asia. These tariffs have raised retail prices in North America and Europe, slowing adoption, but have also encouraged local manufacturing, supply chain diversification, and innovation in cost-efficient devices.
The non-invasive cholesterol reader market research report is one of a series of new reports that provides non-invasive cholesterol reader market statistics, including non-invasive cholesterol reader industry global market size, regional shares, competitors with a non-invasive cholesterol reader market share, detailed non-invasive cholesterol reader market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive cholesterol reader industry. This non-invasive cholesterol reader market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A non-invasive cholesterol reader is a medical device or diagnostic tool used to measure cholesterol levels in the body without the need for blood samples or needles. These devices commonly utilize technologies such as optical sensors, spectroscopy, or electromagnetic waves to detect cholesterol through the skin or other external methods.
The primary product types of non-invasive cholesterol readers include wearable devices, handheld devices, and tabletop devices. Wearable devices are small, body-mounted instruments such as patches, bands, or wristbands that collect physiological data continuously or at regular intervals with minimal discomfort. These devices operate using technologies such as optical, ultrasound, electrical, and others. They are distributed through both online and offline channels and are used across various applications, including home care, hospitals and clinics, diagnostic centers, and other healthcare settings.
The non-invasive cholesterol reader market consists of sales of non-invasive skin cholesterol detection system, stretchable hydrogel-based wearable sensor, and cholesterol monitor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Non-Invasive Cholesterol Reader Market Characteristics
3. Non-Invasive Cholesterol Reader Market Supply Chain Analysis
4. Global Non-Invasive Cholesterol Reader Market Trends and Strategies
5. Non-Invasive Cholesterol Reader Market Analysis of End Use Industries
7. Global Non-Invasive Cholesterol Reader Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Non-Invasive Cholesterol Reader Total Addressable Market (TAM) Analysis for the Market
9. Non-Invasive Cholesterol Reader Market Segmentation
10. Non-Invasive Cholesterol Reader Market Regional and Country Analysis
11. Asia-Pacific Non-Invasive Cholesterol Reader Market
12. China Non-Invasive Cholesterol Reader Market
13. India Non-Invasive Cholesterol Reader Market
14. Japan Non-Invasive Cholesterol Reader Market
15. Australia Non-Invasive Cholesterol Reader Market
16. Indonesia Non-Invasive Cholesterol Reader Market
17. South Korea Non-Invasive Cholesterol Reader Market
18. Taiwan Non-Invasive Cholesterol Reader Market
19. South East Asia Non-Invasive Cholesterol Reader Market
20. Western Europe Non-Invasive Cholesterol Reader Market
21. UK Non-Invasive Cholesterol Reader Market
22. Germany Non-Invasive Cholesterol Reader Market
23. France Non-Invasive Cholesterol Reader Market
24. Italy Non-Invasive Cholesterol Reader Market
25. Spain Non-Invasive Cholesterol Reader Market
26. Eastern Europe Non-Invasive Cholesterol Reader Market
27. Russia Non-Invasive Cholesterol Reader Market
28. North America Non-Invasive Cholesterol Reader Market
29. USA Non-Invasive Cholesterol Reader Market
30. Canada Non-Invasive Cholesterol Reader Market
31. South America Non-Invasive Cholesterol Reader Market
32. Brazil Non-Invasive Cholesterol Reader Market
33. Middle East Non-Invasive Cholesterol Reader Market
34. Africa Non-Invasive Cholesterol Reader Market
36. Non-Invasive Cholesterol Reader Market Competitive Landscape and Company Profiles
37. Non-Invasive Cholesterol Reader Market Other Major and Innovative Companies
40. Non-Invasive Cholesterol Reader Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Non-Invasive Cholesterol Reader Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses non-invasive cholesterol reader market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for non-invasive cholesterol reader? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-invasive cholesterol reader market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Non-Invasive Cholesterol Readers; Handheld Non-Invasive Cholesterol Readers; Tabletop And Benchtop Non-Invasive Cholesterol Readers2) By Technology: Optical Spectroscopy-Based; Near-Infrared (NIR) And Raman Spectroscopy-Based; Electromagnetic And Bio-Impedance-Based; Multi-Sensor Hybrid Technologies; Other Technologies
3) By Distribution Channel: Online; Offline
4) By Application: Home Care And Personal Health Monitoring; Hospitals And Clinics; Diagnostic And Preventive Screening Centers; Research And Clinical Studies; Other Applications
Subsegments:
1) By Wearable Non-Invasive Cholesterol Readers: Wrist-Worn Optical Cholesterol Monitoring Devices; Skin-Patch-Based Non-Invasive Cholesterol Readers; Smart Wearables with Integrated Optical / Spectroscopic Cholesterol Sensors2) By Handheld Non-Invasive Cholesterol Readers: Portable Optical Cholesterol Scanners; Spectroscopy-Based Handheld Cholesterol Readers; Contact-Based Skin Cholesterol Measurement Devices
3) By Tabletop And Benchtop Non-Invasive Cholesterol Readers: Optical Spectroscopy Cholesterol Analysis Systems; Non-Invasive Clinical Cholesterol Screening Units; Research-Grade Benchtop Non-Invasive Cholesterol Measurement Systems
Companies Mentioned: SiPhox Health Inc.; Binah.ai Ltd.; Occuity Ltd.; PreVu Inc.; CardioDiagnostics Inc.; Scanadu Inc.; Aidar Health Inc.; Biovotion AG; Valencell Inc.; Rockley Photonics Inc.; LifeQ B.V.; ChroniSense Medical Ltd.; EchoLabs AI Inc.; Grove Instruments LLC; MediBioSense Health Care; VitalConnect Inc.; Sensible Medical Innovations Ltd.; Current Health Ltd.; Empatica Inc.; BioIntelliSense Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Non-Invasive Cholesterol Reader market report include:- SiPhox Health Inc.
- Binah.ai Ltd.
- Occuity Ltd.
- PreVu Inc.
- CardioDiagnostics Inc.
- Scanadu Inc.
- Aidar Health Inc.
- Biovotion AG
- Valencell Inc.
- Rockley Photonics Inc.
- LifeQ B.V.
- ChroniSense Medical Ltd.
- EchoLabs AI Inc.
- Grove Instruments LLC
- MediBioSense Health Care
- VitalConnect Inc.
- Sensible Medical Innovations Ltd.
- Current Health Ltd.
- Empatica Inc.
- BioIntelliSense Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.5 Billion |
| Forecasted Market Value ( USD | $ 2.63 Billion |
| Compound Annual Growth Rate | 15.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
